CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -98.8% | 257 | -98.4% | 0.00% | – |
| Q1 2021 | $81,000 | -19.8% | 16,000 | 0.0% | 0.00% | – |
| Q4 2020 | $101,000 | +46.4% | 16,000 | 0.0% | 0.00% | – |
| Q3 2020 | $69,000 | -26.6% | 16,000 | 0.0% | 0.00% | – |
| Q2 2020 | $94,000 | +108.9% | 16,000 | +185.7% | 0.00% | – |
| Q1 2019 | $45,000 | -56.7% | 5,600 | -57.6% | 0.00% | – |
| Q4 2018 | $104,000 | -26.8% | 13,200 | 0.0% | 0.00% | – |
| Q3 2018 | $142,000 | -7.8% | 13,200 | 0.0% | 0.00% | – |
| Q2 2018 | $154,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |